-
-
-
-
-
Ab170950-100μg
Rilotumumab (anti-HGF) (C007B-327745)
Price: $103.67List Price: $115.19Rilotumumab (anti-HGF) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab (anti-HGF) shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid -
SML3387-5MG
RILPIVIRINE (C005B-309075)
Price: $177.34List Price: $197.04Biochem/physiol Actions Rilpivirine is a next generation nonnucleoside reverse transcriptase inhibitor (NNRTI), It has been shown to be active against many HIV strains with mutations that confer resistance to the first-generation NNRTIs. -
SML3387-25MG
RILPIVIRINE (C005B-309076)
Price: $532.92List Price: $592.13Biochem/physiol Actions Rilpivirine is a next generation nonnucleoside reverse transcriptase inhibitor (NNRTI), It has been shown to be active against many HIV strains with mutations that confer resistance to the first-generation NNRTIs. -
R647182-100mg
Risarestat (C007B-415620)
Price: $5,377.68List Price: $5,975.19Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.In VivoRisarestat inhibits the accumulation of dulcitol in a dose-dependent manner, except for the 1.0% solution which has an activity -
R647182-10mg
Risarestat (C007B-415621)
Price: $1,034.88List Price: $1,149.86Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.In VivoRisarestat inhibits the accumulation of dulcitol in a dose-dependent manner, except for the 1.0% solution which has an activity -
R647182-25mg
Risarestat (C007B-415622)
Price: $2,104.95List Price: $2,338.83Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.In VivoRisarestat inhibits the accumulation of dulcitol in a dose-dependent manner, except for the 1.0% solution which has an activity -
R647182-50mg
Risarestat (C007B-415623)
Price: $3,507.55List Price: $3,897.27Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.In VivoRisarestat inhibits the accumulation of dulcitol in a dose-dependent manner, except for the 1.0% solution which has an activity -
R647182-5mg
Risarestat (C007B-415624)
Price: $609.20List Price: $676.89Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.In VivoRisarestat inhibits the accumulation of dulcitol in a dose-dependent manner, except for the 1.0% solution which has an activity